Esposito D, Cruciani G, Zaccaro L, di Carlo E, Spitoni G, Manti F
Brain Sci. 2024; 14(5).
PMID: 38790459
PMC: 11119126.
DOI: 10.3390/brainsci14050481.
Toneby M
Wilehm Roux Arch Dev Biol. 2017; 181(3):247-259.
PMID: 28305144
DOI: 10.1007/BF00848424.
Delorme R, Betancur C, Callebert J, Chabane N, Laplanche J, Mouren-Simeoni M
Neuropsychopharmacology. 2005; 30(8):1539-47.
PMID: 15886722
PMC: 1885456.
DOI: 10.1038/sj.npp.1300752.
Gabel S, Stadler J, Bjorn J, Shindledecker R, Bowden C
Child Psychiatry Hum Dev. 1993; 24(2):125-41.
PMID: 7507018
DOI: 10.1007/BF02367265.
Leslie R, Bellamy D, Pyke D
Br Med J. 1980; 280(6206):16-8.
PMID: 7357255
PMC: 1600545.
DOI: 10.1136/bmj.280.6206.16.
Peripheral correlates of serotonergically-influenced behaviors in vervet monkeys (Cercopithecus aethiops sabaeus).
Raleigh M, Yuwiler A, Brammer G, McGuire M, Geller E, Flannery J
Psychopharmacology (Berl). 1981; 72(3):241-6.
PMID: 6784141
DOI: 10.1007/BF00431823.
Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo.
Ross S, Aperia B, BECK-FRIIS J, Jansa S, Wetterberg L, Aberg A
Psychopharmacology (Berl). 1980; 67(1):1-7.
PMID: 6768073
DOI: 10.1007/BF00427588.
Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
Aberg-Wistedt A, Jostell K, Ross S, Westerlund D
Psychopharmacology (Berl). 1981; 74(4):297-305.
PMID: 6457309
DOI: 10.1007/BF00432735.
Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
Arnt J, Overo K, Hyttel J, Olsen R
Psychopharmacology (Berl). 1984; 84(4):457-65.
PMID: 6441945
DOI: 10.1007/BF00431450.
Alaproclate--an open clinical study in depressive illness.
Frost S, Eccleston D, Marshall E, Hassanyeh F
Psychopharmacology (Berl). 1984; 83(3):285-7.
PMID: 6433393
DOI: 10.1007/BF00464796.
Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.
Hyttel J, Overo K, Arnt J
Psychopharmacology (Berl). 1984; 83(1):20-7.
PMID: 6429698
DOI: 10.1007/BF00427416.
Alaproclate: a pharmacokinetic and biochemical study in patients with dementia of Alzheimer type.
Bergman I, Brane G, Gottfries C, Jostell K, Karlsson I, Svennerholm L
Psychopharmacology (Berl). 1983; 80(3):279-83.
PMID: 6412274
DOI: 10.1007/BF00436170.
Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment.
Ross S, Aberg-Wistedt A
Psychopharmacology (Berl). 1983; 79(4):298-303.
PMID: 6222388
DOI: 10.1007/BF00433405.
Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat.
Ross S, Hall H, RENYI A, Westerlund D
Psychopharmacology (Berl). 1981; 72(3):219-25.
PMID: 6164072
DOI: 10.1007/BF00431820.
Examination of circadian rhythmicity of blood serotonin and platelets in autistic and non-autistic children.
Yuwiler A, Ritvo E, Bald D, Kipper D, Koper A
J Autism Child Schizophr. 1971; 1(4):421-35.
PMID: 5173772
DOI: 10.1007/BF01540533.
A simple routine-method to preserve and determine blood serotonin.
Geeraerts F, Schimpfessel L, CROKAERT R
Experientia. 1974; 30(7):837.
PMID: 4847694
DOI: 10.1007/BF01924220.
Blood serotonin in psychotic and brain damaged children.
Campbell M, Friedman E, DEVITO E, Greenspan L, Collins P
J Autism Child Schizophr. 1974; 4(1):33-41.
PMID: 4596896
DOI: 10.1007/BF02104998.
Effects of L-dopa in autism.
Ritvo E, Yuwiler A, Geller E, Kales A, Rashkis S, Schicor A
J Autism Child Schizophr. 1971; 1(2):190-205.
PMID: 4335857
DOI: 10.1007/BF01537957.
Effects of pyridoxine deficiency and DL-p-chlorophenylalanine administration to rats on 5-hydroxytryptamine and noradrenaline concentrations in brain and 5-hydroxytryptamine concentration in blood.
Bhagavan H, Coursin D
Biochem J. 1973; 134(3):763-7.
PMID: 4270682
PMC: 1177873.
DOI: 10.1042/bj1340763.
Clinical effects of fenfluramine in ten autistic subjects.
Klykylo W, Feldis D, OGrady D, Ross D, Halloran C
J Autism Dev Disord. 1985; 15(4):417-23.
PMID: 4077816
DOI: 10.1007/BF01531786.
